Pharmafile Logo
Pharmafocus logo
Advanced Search

MC2 Therapeutics

Showing 1 posts of 1 posts found.

almirall-605x338

MC2 Therapeutics grants Almirall European commercial rights for psoriasis cream Wynzora

February 18, 2021
Almirall, MC2 Therapeutics, psoriasis

Biopharma company Almirall and MC2 Therapeutics, a pharmaceutical company focused on therapies for autoimmune and chronic inflammatory conditions, have announced …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024